- Category
- Micro (2022-23)
- Udyam number
- UDYAM-DL-01-0027262

Bitco Pharmaceutical Private Limited
About Bitco Pharmaceutical Private Limited
Data last updated:
Bitco Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 February 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2022PTC393713.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Kumari Mukta Priyadarshni and Kusum.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No F – 46 1st Floor Lsc Vardhman Central Mall Nehru Vihar Market, Delhi, India – 110054.
As per the financials filed for FY 2025, the company reported a revenue of ₹43.18 Lakh, a growth of 78% compared to the previous year. For the same year it recorded a net profit of ₹44,525 (net margin 1%) and EBITDA of ₹71,684 (EBITDA margin 1.7%).
The company has about 5 employees on its provident fund (EPFO) records.
Bitco Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0027262).
Recognitions & Rankings of Bitco Pharmaceutical
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressUnit No F – 46 1st Floor Lsc Vardhman Central Mall Nehru Vihar Market, Delhi, India – 110054
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bitco Pharmaceutical Private Limited
The main business activity of Bitco Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bitco Pharmaceutical Private Limited FY 2025 filings available
Bitco Pharmaceutical Private Limited reported revenue of ₹43.18 Lakh (up 78% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Bitco Pharmaceutical Private Limited
Revenue rose 78% in the latest year. EBITDA rose 382% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Bitco Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹71,684 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹44,525 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Bitco Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bitco Pharmaceutical are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Bitco Pharmaceutical Private Limited
Bitco Pharmaceutical has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumari Mukta Priyadarshni | Director | 11 Feb 2022 | 4 Years 8 Months | Current |
| Kusum | Director | 11 Feb 2022 | 4 Years 8 Months | Current |
| Rahul Sharma | Director | 22 Oct 2024 | 1 Years 11 Months | Current |
| Babli | Director | 22 Oct 2024 | 1 Years 11 Months | Current |
Peer Comparison of Bitco Pharmaceutical Private Limited
Bitco Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Induct Pharmaceuticals Private Limited | ₹43.2 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Surat, Gujarat, India |
| K. F. Plyarts Private Limited | ₹43.19 Lakh (FY 2022) | •••• | •••• | -17.0% | •••• | Kanpur, Uttar Pradesh, India |
| A.R. Remedies Private Limited | ₹43.19 Lakh (FY 2019) | •••• | •••• | 145.0% | •••• | Lucknow, Uttar Pradesh, India |
| Vedik Alloys Private Limited | ₹43.19 Lakh (FY 2024) | •••• | •••• | 10.0% | •••• | Thane, Maharashtra, India |
| Midastouch Dyes and Intermediaries Limited | ₹43.18 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Bitco Pharmaceutical Private Limited this company | ₹43.18 Lakh (FY 2025) | •••• | •••• | 78.0% | •••• | Delhi, India |
| RTN Pharma Private Limited | ₹43.18 Lakh (FY 2022) | •••• | •••• | 697.0% | •••• | Hosur, Tamil Nadu, India |
| N2n Ingredients Private Limited | ₹43.17 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Tripunithura, Kerala, India |
| Vajire Ishwar Farmer Producer Company Limited | ₹43.16 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Nanded, Maharashtra, India |
| Medicon Ophthalmics Private Limited | ₹43.15 Lakh (FY 2021) | •••• | •••• | -36.0% | •••• | New Delhi, Delhi, India |
| Fashpert Online Services Private Limited | ₹43.13 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Meerut, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Bitco Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Bitco Pharmaceutical Private Limited
Bitco Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bitco Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Bitco Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bitco Pharmaceutical Private Limited
Bitco Pharmaceutical Private Limited has 5 board changes on record since 2022: 4 appointments and 1 cessation. The latest: Babli was appointed as Director on 22 Oct 2024.
Credit Ratings, Litigation & Regulatory Alerts for Bitco Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bitco Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bitco Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bitco Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bitco Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bitco Pharmaceutical Private Limited
Bitco Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 February 2022 (4+ years old) and is registered under CIN U24230DL2022PTC393713.
Bitco Pharmaceutical reported revenue of ₹43.18 Lakh for FY 2025 (up 78% YoY).
Bitco Pharmaceutical has 4 current directors:
- Kumari Mukta Priyadarshni - Director
- Kusum - Director
- Rahul Sharma - Director
- Babli - Director
Bitco Pharmaceutical reported a net profit of ₹44,525 (net margin 1%) and EBITDA of ₹71,684 (EBITDA margin 1.7%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Bitco Pharmaceutical is U24230DL2022PTC393713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bitco Pharmaceutical was incorporated on 11 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Bitco Pharmaceutical by revenue are Induct Pharmaceuticals Private Limited, K. F. Plyarts Private Limited, A.R. Remedies Private Limited, Vedik Alloys Private Limited, Midastouch Dyes and Intermediaries Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Babli was appointed as Director on 22 Oct 2024. Rahul Sharma was appointed as Director on 22 Oct 2024. Sonu Kumar ceased to be Director on 22 Oct 2024. Bitco Pharmaceutical has 5 board changes on record in total.
Yes, Bitco Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0027262).
The registered office of Bitco Pharmaceutical is at Unit No F – 46 1st Floor Lsc Vardhman Central Mall Nehru Vihar Market, Delhi, India – 110054.
Bitco Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh.